SCIESCOPUSQ1
JOURNAL OF CLINICAL ONCOLOGY
LIPPINCOTT WILLIAMS & WILKINS, United States
JOURNAL OF CLINICAL ONCOLOGY is an academic journal published by LIPPINCOTT WILLIAMS & WILKINS (United States). Identifiers: ISSN 0732-183X, eISSN 1527-7755. Indexed in SCIE, SCOPUS. Metrics: JIF 41.9, CiteScore 38.9, SJR 11.205, SNIP 5.98. Subject areas: ONCOLOGY. tlooto lists 122,021 papers from this journal.
CiteScore
38.90
Scopus citation metric
SJR
11.205
SCImago rank
SNIP
5.98
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Abbreviation
- J CLIN ONCOL
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Country
- United States
Web of Science categories
SCIEONCOLOGY
Scopus ASJC categories
1306 Cancer Research2730 Oncology
Keywords
Oncology
Papers in this journal
Recent papers
- The early discharge clinic: A safe and efficient model for intensive outpatient management of hematologic malignancies.
2026
- A multi-institutional, randomized, phase III trial comparing anatomical segmentectomy and lobectomy for clinical stage IA3 pure-solid non–small-cell lung cancer: West Japan Oncology Group study WJOG16923L (STEP UP trial).
2026 · 1 citations
- A phase 2 study of neoadjuvant nivolumab + relatlimab versus nivolumab in patients with resectable high-risk basal cell carcinoma.
2026
- Comparison of talquetamab vs teclistamab in relapsed refractory multiple myeloma.
2026
- Multi-omic ctDNA-based MRD for predicting clinical outcomes in advanced NSCLC receiving chemoimmunotherapy.
2026
Most cited papers
- J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2014 · 2,563 citations
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 · 2,435 citations
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
2009 · 2,190 citations
- Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2023 · 1,862 citations
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
2021 · 1,621 citations